Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: August 12, 2019
Reporting Period: First quarter ended June 30, 2019
Context: The filing serves to announce the Company's financial and operating results for the first quarter of 2019 via a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data points. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are contained within the referenced press release (Exhibit 99.1), which is not included in the input text. Therefore, the filing text does not provide a clear value for these metrics.
Material Changes
No material changes or comparative financial data versus prior periods are detailed in the provided text. The document solely references the issuance of the Q1 2019 results.
Guidance, Outlook, and Risks
Management Commentary: The filing indicates that management has issued a press release regarding Q1 2019 results, but the content of that commentary is not present in the text.
Legal Disclaimer: The information in this Current Report and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933. Furthermore, this information shall not be incorporated by reference into any registration statement unless expressly set forth by specific reference.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific Q1 2019 financial figures, as they are not listed in the 8-K cover sheet.
- Verify the Company's status as an "emerging growth company" and its election regarding the extended transition period for financial accounting standards.
- Confirm the trading symbol (INMB) and exchange (NASDAQ) for the Common Stock.
- Note the legal limitation that this specific 8-K filing does not incorporate the press release by reference into future registration statements without explicit citation.